Peptone
Dr. George Golumbeski has over 30 years of experience in the pharmaceutical and biotechnology industry. He is currently focused on new company creation and new company building. He is working on these objectives as a partner at DROIA Ventures where he focuses on “NewCos” dedicated to therapies for genetically defined diseases. He also serves as a Director for Sage Therapeutics, Vice Chair for MorphoSys, and Chair of the Board for Carrick Therapeutics and Shattuck Labs.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Peptone
2 followers
Peptone is a UK-based startup that is helping pharmaceutical companies unravel the secrets of proteins.